PNPLA3 and metabolic dysfunction-associated steatotic liver disease: For example, the regulatory region of PNPLA3 was hypermethylated in human liver biopsy samples, with PNPLA3 mRNA levels being lower in patients with advanced NAFLD compared with those with mild NAFLD, demonstrating a relationship with the severity of the disease (Table 1) [44].